SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-06-027487
Filing Date
2006-04-25
Accepted
2006-04-25 17:29:51
Documents
2
Period of Report
2006-05-19
Effectiveness Date
2006-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a06-8569_1def14a.htm DEF 14A 572978
2 GRAPHIC g85691bai001.jpg GRAPHIC 23905
  Complete submission text file 0001104659-06-027487.txt   607718
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 06778982
SIC: 2834 Pharmaceutical Preparations